Potential mechanisms for the regulation of growth factor binding by heparin

Journal of Theoretical Biology

Volumn 205, Issue 2, 2000, Pages 215-230

  Forsten, Kimberly E ^a   Fannon, Michael ^b,c   Nugent, Matthew A ^b  

^a Virginia Polytechnic Institute and State University   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HEPARIN; PROTEOHEPARAN SULFATE;

ARTICLE; BINDING SITE; CELL SURFACE; GROWTH REGULATION; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REPRODUCIBILITY;

EID: 0034698012     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.2000.2064     Document Type: Article

References (38)

1. Physics of chemoreception
2. Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development
3. Evidence that carboxyl-reduced heparin fails to potentiate acidic fibroblast growth factor activity due to an inability to interact with cell surface heparin receptors
4. Binding and internalization of heparin by vascular smooth muscle cells
5. Heparin structures and interactions with basic fibroblast growth factor
6. Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response
7. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA sythesis in Balb/c3T3 cells in the absence of heparan sulfate
8. Endothelial proteoglycans inhibit bFGF binding and mitogenesis
9. Probability of autocrine ligand capture by cell-surface receptors: Implications for ligand secretion measurements
10. The role of low-affinity interleukin-2 receptors in autocrine ligand binding: Alternative mechanisms for an enhanced binding effect
11. Heparin can activate a receptor tyrosine kinase
12. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan
13. Heparin-induced self-association of fibroblast growth factor-2 - Evidence for two oligomerization processes
14. LSODE and LSODI, two new initial value ordinary differential equation solvers
15. An essential heparin-binding domain in the fibroblast growth factor receptor kinase
16. Specificity for fibroblast growth factors detrermined by heparan sulfate in a binary complex with the receptor kinase
17. Heparin binding, internalization and metabolismin vascular smooth muscle cells. I. Up-regulation of heparin binding correlates with antiproliferative activity
18. The heparan sulfate-fibroblast growth factor family: Diversity of structure and function
19. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex
20. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound
21. The core protein of the chondroitin sulfate proteoglycan phoshacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity
22. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix
23. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: A mechanism for cooperativity
24. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
25. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization
26. Structural basis for FGF receptor dimerization and activation
27. Binding of heparin to basic fibroblast growth factor induces a conformational change
28. Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for call activation
29. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation
30. Highlights in the history of heparin
31. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding
32. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation
33. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex
34. Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans
35. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
36. Heparin protein interactions
37. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?